Abstract
CD8<sup>+</sup> T cell‑related KCTD5 contributes to malignant progression and unfavorable clinical outcome of patients with triple‑negative breast cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have